Preventative vaccines are administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts as a decoy) into the body, the immune system reacts by producing antibodies. If years later, the virus enters the organism, these antibodies will recognise and destroy it.
The Middle East & Africa Preventive Vaccines Market Segments Size & Growth:
The Middle East & Africa preventive vaccines market size is projected to reach approximately $28 billion by the end of 2024 with a CAGR of close to 6.6% from $20 billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include Huge market demand, Higher profitability and improved technology, Government funded projects and Associations, Increasing demand, and a higher onset of diseases. However, High regulatory intervention and cost and Increasing demand for cost-effective vaccines are thereby hampering the market growth.
The Middle East & Africa Preventive Vaccines Market Segments Share:
The Middle East & Africa, preventive vaccines market, is segmented based on the type
Starting from $2700
Starting from $2700
Starting from $2700
Keep up-to-date with our weekly newsletter, Media Pulse.